---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-021669"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T23:16:40.078339+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hillstream BioPharma receives Nasdaq notice for bid price below $1.00 per share

## Summary
- Nasdaq notified Hillstream on June 12, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 days until Dec 11, 2023 to regain compliance by closing at $1.00 for 10 consecutive days.
- If not compliant by Dec 11, may qualify for second 180-day period; otherwise delisting with appeal option.
- Hillstream intends to actively monitor closing bid price and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001493152-23-021669
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315223021669/0001493152-23-021669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315223021669/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-021669
- JSON: https://secwatch.observer/filing/0001493152-23-021669.json
- Plain text: https://secwatch.observer/filing/0001493152-23-021669.txt

## Key facts
- Listing & Compliance Notices
  Canton Strategic Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: June 12, 2023, Hillstream BioPharma, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock (the “Common Stock”), for the last 30 consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no effect at this time of the Common Stock, which continues to trade on
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000149315223021669/0001493152-23-021669-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.